These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

236 related items for PubMed ID: 27140506

  • 1. Voglibose-inspired synthesis of new potent α-glucosidase inhibitors N-1,3-dihydroxypropylaminocyclitols.
    Worawalai W, Sompornpisut P, Wacharasindhu S, Phuwapraisirisan P.
    Carbohydr Res; 2016 Jun 24; 429():155-62. PubMed ID: 27140506
    [Abstract] [Full Text] [Related]

  • 2. N-Arylmethylaminoquercitols, a new series of effective antidiabetic agents having α-glucosidase inhibition and antioxidant activity.
    Worawalai W, Wacharasindhu S, Phuwapraisirisan P.
    Bioorg Med Chem Lett; 2015 Jun 15; 25(12):2570-3. PubMed ID: 25959812
    [Abstract] [Full Text] [Related]

  • 3. Furofuran lignans as a new series of antidiabetic agents exerting α-glucosidase inhibition and radical scarvenging: Semisynthesis, kinetic study and molecular modeling.
    Worawalai W, Doungwichitrkul T, Rangubpit W, Taweechat P, Sompornpisut P, Phuwapraisirisan P.
    Bioorg Chem; 2019 Jun 15; 87():783-793. PubMed ID: 30978603
    [Abstract] [Full Text] [Related]

  • 4. Synthesis and biological evaluation of 2-acylbenzofuranes as novel α-glucosidase inhibitors with hypoglycemic activity.
    Spasov AA, Babkov DA, Prokhorova TY, Sturova EA, Muleeva DR, Demidov MR, Osipov DV, Osyanin VA, Klimochkin YN.
    Chem Biol Drug Des; 2017 Dec 15; 90(6):1184-1189. PubMed ID: 28585419
    [Abstract] [Full Text] [Related]

  • 5. Divergent synthesis of new α-glucosidase inhibitors obtained through a vinyl Grignard-mediated carbocyclisation.
    Knudsen IMB, Hedberg C, Ladefoged LK, Ide D, Brinkø A, Eikeland EZ, Kato A, Jensen HH.
    Org Biomol Chem; 2018 Aug 29; 16(34):6250-6261. PubMed ID: 30110037
    [Abstract] [Full Text] [Related]

  • 6. Synthesis, in vitro evaluation and molecular docking studies of novel triazine-triazole derivatives as potential α-glucosidase inhibitors.
    Wang G, Peng Z, Wang J, Li X, Li J.
    Eur J Med Chem; 2017 Jan 05; 125():423-429. PubMed ID: 27689725
    [Abstract] [Full Text] [Related]

  • 7. Design, synthesis, docking study, α-glucosidase inhibition, and cytotoxic activities of acridine linked to thioacetamides as novel agents in treatment of type 2 diabetes.
    Mohammadi-Khanaposhtani M, Rezaei S, Khalifeh R, Imanparast S, Faramarzi MA, Bahadorikhalili S, Safavi M, Bandarian F, Nasli Esfahani E, Mahdavi M, Larijani B.
    Bioorg Chem; 2018 Oct 05; 80():288-295. PubMed ID: 29980114
    [Abstract] [Full Text] [Related]

  • 8. Synthesis and the intestinal glucosidase inhibitory activity of 2-aminoresorcinol derivatives toward an investigation of its binding site.
    Kato E, Oikawa K, Takahashi K, Kawabata J.
    Biosci Biotechnol Biochem; 2012 Oct 05; 76(5):1044-6. PubMed ID: 22738986
    [Abstract] [Full Text] [Related]

  • 9. Exploring the Dual Inhibitory Activity of Novel Anthranilic Acid Derivatives towards α-Glucosidase and Glycogen Phosphorylase Antidiabetic Targets: Design, In Vitro Enzyme Assay, and Docking Studies.
    Ihmaid S.
    Molecules; 2018 May 29; 23(6):. PubMed ID: 29844263
    [Abstract] [Full Text] [Related]

  • 10. A new entry into the portfolio of α-glucosidase inhibitors as potent therapeutics for type 2 diabetes: Design, bioevaluation and one-pot multi-component synthesis of diamine-bridged coumarinyl oxadiazole conjugates.
    Kazmi M, Zaib S, Ibrar A, Amjad ST, Shafique Z, Mehsud S, Saeed A, Iqbal J, Khan I.
    Bioorg Chem; 2018 Apr 29; 77():190-202. PubMed ID: 29421697
    [Abstract] [Full Text] [Related]

  • 11. Exploration of aroyl/heteroaroyl iminothiazolines featuring 2,4,5-trichlorophenyl moiety as a new class of potent, selective, and in vitro efficacious glucosidase inhibitors.
    Kazmi M, Zaib S, Amjad ST, Khan I, Ibrar A, Saeed A, Iqbal J.
    Bioorg Chem; 2017 Oct 29; 74():134-144. PubMed ID: 28780150
    [Abstract] [Full Text] [Related]

  • 12. Synthesis and biological evaluation of α-1-C-4'-arylbutyl-L-arabinoiminofuranoses, a new class of α-glucosidase inhibitors.
    Natori Y, Sakuma T, Yoshimura Y, Kinami K, Hirokami Y, Sato K, Adachi I, Kato A, Takahata H.
    Bioorg Med Chem Lett; 2014 Aug 01; 24(15):3298-301. PubMed ID: 24973028
    [Abstract] [Full Text] [Related]

  • 13. Synthetic heterocyclic candidates as promising α-glucosidase inhibitors: An overview.
    Dhameja M, Gupta P.
    Eur J Med Chem; 2019 Aug 15; 176():343-377. PubMed ID: 31112894
    [Abstract] [Full Text] [Related]

  • 14. Pyridine sulfonamide as a small key organic molecule for the potential treatment of type-II diabetes mellitus and Alzheimer's disease: In vitro studies against yeast α-glucosidase, acetylcholinesterase and butyrylcholinesterase.
    Riaz S, Khan IU, Bajda M, Ashraf M, Qurat-Ul-Ain, Shaukat A, Rehman TU, Mutahir S, Hussain S, Mustafa G, Yar M.
    Bioorg Chem; 2015 Dec 15; 63():64-71. PubMed ID: 26451651
    [Abstract] [Full Text] [Related]

  • 15. Synthesis, Biological Evaluation and Molecular Docking Study of 2-Substituted-4,6-Diarylpyrimidines as α-Glucosidase Inhibitors.
    Gong Z, Xie Z, Qiu J, Wang G.
    Molecules; 2017 Oct 30; 22(11):. PubMed ID: 29084182
    [Abstract] [Full Text] [Related]

  • 16. Design, synthesis, molecular modelling, ADME prediction and anti-hyperglycemic evaluation of new pyrazole-triazolopyrimidine hybrids as potent α-glucosidase inhibitors.
    Pogaku V, Gangarapu K, Basavoju S, Tatapudi KK, Katragadda SB.
    Bioorg Chem; 2019 Dec 30; 93():103307. PubMed ID: 31585262
    [Abstract] [Full Text] [Related]

  • 17. Design and synthesis of novel xanthone-triazole derivatives as potential antidiabetic agents: α-Glucosidase inhibition and glucose uptake promotion.
    Ye GJ, Lan T, Huang ZX, Cheng XN, Cai CY, Ding SM, Xie ML, Wang B.
    Eur J Med Chem; 2019 Sep 01; 177():362-373. PubMed ID: 31158750
    [Abstract] [Full Text] [Related]

  • 18. Pyrano[3,2-c]quinoline Derivatives as New Class of α-glucosidase Inhibitors to Treat Type 2 Diabetes: Synthesis, in vitro Biological Evaluation and Kinetic Study.
    Heydari Z, Mohammadi-Khanaposhtani M, Imanparast S, Faramarzi MA, Mahdavi M, Ranjbar PR, Larijani B.
    Med Chem; 2019 Sep 01; 15(1):8-16. PubMed ID: 29807519
    [Abstract] [Full Text] [Related]

  • 19. Synthesis and molecular docking studies of potent α-glucosidase inhibitors based on biscoumarin skeleton.
    Khan KM, Rahim F, Wadood A, Kosar N, Taha M, Lalani S, Khan A, Fakhri MI, Junaid M, Rehman W, Khan M, Perveen S, Sajid M, Choudhary MI.
    Eur J Med Chem; 2014 Jun 23; 81():245-52. PubMed ID: 24844449
    [Abstract] [Full Text] [Related]

  • 20. Dietary Flavonoids and Acarbose Synergistically Inhibit α-Glucosidase and Lower Postprandial Blood Glucose.
    Zhang BW, Li X, Sun WL, Xing Y, Xiu ZL, Zhuang CL, Dong YS.
    J Agric Food Chem; 2017 Sep 27; 65(38):8319-8330. PubMed ID: 28875706
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.